Prevalence and impact on the outcome of myosteatosis in patients with cirrhosis: a systematic review and meta-analysis
ConclusionMyosteatosis is highly prevalent in patients with cirrhosis, particularly in those with NAFLD-associated cirrhosis. Myosteatosis is associated with hepatic encephalopathy, while it seems to have a negative impact on the outcome.
Source: Hepatology International - Category: Infectious Diseases Source Type: research
More News: Alcoholism | Bleeding | Cirrhosis | Diabetes | Diabetes Mellitus | Endocrinology | Fatty Liver Disease (FLD) | Infectious Diseases | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Statistics | Study | Urology & Nephrology | Women